Neu H C
College of Physicians & Surgeons, Columbia University, New York, New York 10032.
Scand J Infect Dis Suppl. 1993;91:7-13.
There is and has been continued change in organisms causing infection in the hospital. In the past few years, although Gram-negative bacteria have remained a major cause of mortality, Gram-positive bacteria and fungi have become increasingly important. This has caused organisms such as methicillin-resistant staphylococci, enterococci, Xanthomonas maltophilia and multiply resistant Pseudomonas aeruginosa to be common pathogens. Can this difficult state of affairs be changed by better antimicrobial prescribing practices? Yes and no. Virtually any agent will select MRSA and MRSE since the chromosomal location of the resistance of multiple-antibiotics makes such selection common and explains the rapid rate of the fluoroquinolones as therapy of MRSA. Restriction of oral vancomycin will markedly reduce the pressure to select Enterococcus faecium and thus limit the spread of the organisms and delay transmission of glycopeptide resistance to S. aureus. Judicious use of antibiotics in the intensive care environment will be major factor in "saving" antibiotics for other patients since the ICU patient goes to other parts of the hospital carrying with him/her the baggage of resistant Staphylococcus haemolyticus, klebsiella, P. aeruginosa, acinetobacter, enterobacter, xanthomonas and Pseudomonas cepacia. All of these organisms have the potential to become resistant to the agents heretofore used to treat them and are common in ICU patients.
医院中引发感染的生物体一直在持续变化。在过去几年里,尽管革兰氏阴性菌仍是导致死亡的主要原因,但革兰氏阳性菌和真菌变得越来越重要。这使得耐甲氧西林葡萄球菌、肠球菌、嗜麦芽窄食单胞菌和多重耐药的铜绿假单胞菌等生物体成为常见病原体。更好的抗菌药物处方做法能否改变这种艰难的状况?答案是肯定的,也是否定的。实际上,几乎任何一种药物都会选择出耐甲氧西林金黄色葡萄球菌和耐甲氧西林表皮葡萄球菌,因为多种抗生素耐药性的染色体定位使得这种选择很常见,这也解释了氟喹诺酮类药物作为耐甲氧西林金黄色葡萄球菌治疗药物的快速应用率。限制口服万古霉素将显著降低选择屎肠球菌的压力,从而限制这些生物体的传播,并延缓糖肽类耐药性向金黄色葡萄球菌的传播。在重症监护环境中明智地使用抗生素将是为其他患者“节省”抗生素的主要因素,因为重症监护病房的患者前往医院其他科室时会携带溶血葡萄球菌、克雷伯菌、铜绿假单胞菌、不动杆菌、肠杆菌、嗜麦芽窄食单胞菌和洋葱伯克霍尔德菌等耐药菌。所有这些生物体都有可能对以前用于治疗它们的药物产生耐药性,并且在重症监护病房患者中很常见。